Confused by conflicting studies about the link between viagra and Alzheimer’s? Two experts explain the disparaties
Academic rigor, journalistic flair
Articles on Alzheimer's research
Displaying all articles
Two thirds of people with Alzheimer’s disease are women – but activation of a brain protein called CYP46A1 might hold the key to prevention.
Disorders such as Alzheimer’s and epilepsy are difficult to diagnose with only occasional doctor visits. A new approach would allow fathering of extensive real-world data directly from patients.
The drug has been hailed as a ‘turning point’ in Alzheimer’s treatment. But keep in mind the trial only included participants with early or mild disease. And while it slowed decline, it’s not a cure.
People living with dementia often become more confused in the late afternoon and into the night. Why, and what can we do about it?
Impaired insulin receptors in the blood vessels between the blood and the brain may contribute to the insulin resistance observed in Alzheimer’s disease.
Alzheimer’s may not be primarily a disease of the brain. It may be a disorder of the immune system within the brain. Beta-amyloid may not be an abnormal protein, but part of the brain’s immune system.
Top contributors
-
Head of Clinical Services, Dementia Support Australia, & Associate Professor of Psychiatry, Monash University
-
Professeur, Université Laval
-
Professor of Chemistry and Senior Scientist of the Krembil Research Institute, University Health Network, University of Toronto
-
PhD student, Université Laval
-
Professor in Clinical Pharmacy, Aston University
-
Associate professor and research group leader, Neurobiology, Karolinska Institutet
-
Research director at the Decision Support Systems (DSS) Laboratory, National Technical University of Athens
-
Senior lecturer in Pharmacoepidemiology, Aston University
-
Professionnel de recherche, Université Laval
